Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts

Table 2 FibroMax® scores according to CACS in the DIACART cohort

FibroMax® scores	Total	CACS				P-value for trend
FibroMax® scores	Total	0–10	> 10–100	> 100–400	> 400	P-value for trend
n	157	15	13	32	97
ActiTest® score	0.12 [0.08–0.18]	0.12 [0.08–0.19]	0.10 [0.06–0.22]	0.12 [0.08–0.16]	0.12 [0.07–0.18]	0.98
NashTest® score	0.50 [0.25–0.50]	0.50 [0.25–0.63]	0.50 [0.25–0.50]	0.50 [0.50–0.50]	0.50 [0.25–0.50]	0.24
SteatoTest® score	0.539 ± 0.208	0.584 ± 0.209	0.481 ± 0.183	0.626 ± 0.151	0.512 ± 0.219	0.11
FibroTest® score	0.372 ± 0.212	0.249 ± 0.112	0.275 ± 0.246	0.354 ± 0.201	0.411 ± 0.212	0.002

Data are presented as the mean ± standard deviation (for normally-distributed variables) or median [1st–3rd quartiles] (for skewed variables), as appropriate. Bold is used when the p-value < 0.05
CACS coronary artery calcium score

ISSN: 1475-2840